Skin-Disease Focused Biotech Castle Creek Files $100M IPO
Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS.
Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022
Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market.
The $100 million IPO will support Phase 2/3 trials that CEO Tillman Gerngross’ Adagio is running to position ADG20 to treat and prevent COVID-19.
Celularity Closes SPAC Merger With GX Acquisition, Trading Starts Monday
Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ:GXGX), giving Celularity $138 million to push the NK cell and…
Alibaba, SoftBank Backed Indian Online Payment Startup Paytm Eyes $2.2B IPO: TechCrunch
Indian digital payments startup, Paytm, plans to raise $2.2 billion in an initial public offering, TechCrunch reports.
Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO
Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut.
Precision Oncology-Focused Biotech Nuvalent Files For $100M IPO
Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent (NASDAQ: NUVL) is already prepping a Nasdaq debut.
Rare Disease Biotech Rallybio Targets $100M IPO
Rallybio Corporation (NASDAQ:RLYB) ended the first quarter with nearly $128 million in the bank, and now it has filed to…
GIC-Backed WCG Clinical Plans $100M NASDAQ Debut
WCG Clinical Inc (NASDAQ: WCGC), a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering in the U.S. on Thursday to trade on NASDAQ under the "WCGC" symbol.
Caribou Biosciences Eyes $100M NASDAQ Debut To Propel Off-The-Shelf CAR-T Therapies In Blood Cancer
In a filing with SEC on Thursday, Caribou Biosciences (NASDAQ:CRBU) is penciling in a $100 million initial public offering. The firm…
Intapp Prices IPO At $26 Per Share; Trading Begins Today
Cloud-based software solutions provider Intapp Inc (NASDAQ:INTA) priced 10.5 million shares at $26 per share in its initial public offering. The…